Breland E. Smith

678 total citations
16 papers, 528 citations indexed

About

Breland E. Smith is a scholar working on Pharmacology, Toxicology and Molecular Biology. According to data from OpenAlex, Breland E. Smith has authored 16 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Toxicology and 4 papers in Molecular Biology. Recurrent topics in Breland E. Smith's work include Cannabis and Cannabinoid Research (5 papers), Forensic Toxicology and Drug Analysis (5 papers) and Down syndrome and intellectual disability research (3 papers). Breland E. Smith is often cited by papers focused on Cannabis and Cannabinoid Research (5 papers), Forensic Toxicology and Drug Analysis (5 papers) and Down syndrome and intellectual disability research (3 papers). Breland E. Smith collaborates with scholars based in United States, Italy and Germany. Breland E. Smith's co-authors include Christopher Hulme, Vijay Gokhale, Travis Dunckley, Federico Medda, Robert L. Fitzgerald, Jacqueline A. Hubbard, Thomas D. Marcotte, Igor Grant, David J. Grelotti and Timothy D. Lash and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Clinical Chemistry.

In The Last Decade

Breland E. Smith

16 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Breland E. Smith United States 12 190 152 119 97 87 16 528
Davide Guerrieri Italy 15 54 0.3× 253 1.7× 66 0.6× 168 1.7× 107 1.2× 19 709
Jakub Wojcieszak Poland 15 137 0.7× 276 1.8× 71 0.6× 436 4.5× 27 0.3× 27 854
Susan L. Mercer United States 15 92 0.5× 257 1.7× 91 0.8× 106 1.1× 58 0.7× 26 554
Noriyuki Usami Japan 16 192 1.0× 184 1.2× 37 0.3× 50 0.5× 14 0.2× 27 656
Ling‐Wei Hsin Taiwan 16 78 0.4× 409 2.7× 255 2.1× 27 0.3× 14 0.2× 47 827
Azza Baraka Egypt 11 56 0.3× 174 1.1× 346 2.9× 21 0.2× 18 0.2× 22 720
F. Shalit Israel 13 48 0.3× 154 1.0× 66 0.6× 117 1.2× 36 0.4× 14 681
Kamila Czarnecka Poland 14 173 0.9× 142 0.9× 159 1.3× 14 0.1× 12 0.1× 36 541
Ewelina Honkisz-Orzechowska Poland 13 62 0.3× 147 1.0× 76 0.6× 23 0.2× 12 0.1× 25 388
Paolo Lazzari Italy 18 385 2.0× 267 1.8× 232 1.9× 22 0.2× 11 0.1× 43 847

Countries citing papers authored by Breland E. Smith

Since Specialization
Citations

This map shows the geographic impact of Breland E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Breland E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Breland E. Smith more than expected).

Fields of papers citing papers by Breland E. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Breland E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Breland E. Smith. The network helps show where Breland E. Smith may publish in the future.

Co-authorship network of co-authors of Breland E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Breland E. Smith. A scholar is included among the top collaborators of Breland E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Breland E. Smith. Breland E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Foley, Christopher, Breland E. Smith, Aaron Babendreyer, et al.. (2024). Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B. Journal of Medicinal Chemistry. 67(19). 17259–17289. 6 indexed citations
2.
Marcotte, Thomas D., Anya Umlauf, David J. Grelotti, et al.. (2022). Driving Performance and Cannabis Users’ Perception of Safety. JAMA Psychiatry. 79(3). 201–201. 59 indexed citations
3.
Hoffman, Melissa, Jacqueline A. Hubbard, Breland E. Smith, et al.. (2021). Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers. Journal of Analytical Toxicology. 45(8). 851–862. 16 indexed citations
4.
Hubbard, Jacqueline A., Melissa Hoffman, Shannon Ellis, et al.. (2021). Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath. Journal of Analytical Toxicology. 45(8). 820–828. 24 indexed citations
5.
Smith, Breland E., Jacqueline A. Hubbard, Thomas D. Marcotte, et al.. (2019). Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid. Clinica Chimica Acta. 491. 30–38. 30 indexed citations
6.
Velázquez, Ramón, Bessie Meechoovet, Christopher Foley, et al.. (2019). Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice. Molecular Neurobiology. 56(12). 8364–8375. 30 indexed citations
7.
Hubbard, Jacqueline A., Breland E. Smith, Sollip Kim, et al.. (2019). Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath. Clinical Chemistry and Laboratory Medicine (CCLM). 58(5). 673–681. 42 indexed citations
8.
Young, Jeffrey A., et al.. (2018). The Missing Metabolite: How Unexpected Urine Drug Metabolite Patterns May Lead to False Interpretations. Clinical Chemistry. 64(9). 1291–1293. 3 indexed citations
9.
Smith, Breland E., et al.. (2018). Interpretation of Pain Management Testing Results Using Case Examples. The Journal of Applied Laboratory Medicine. 2(4). 610–621. 6 indexed citations
10.
Smith, Breland E., Amy K. Saenger, Fred S. Apple, et al.. (2018). Multicenter assessment of a hemoglobin A1c point-of-care device for diagnosis of diabetes mellitus. Clinical Biochemistry. 61. 18–22. 8 indexed citations
11.
Branca, Caterina, Ramona Belfiore, Vijay Gokhale, et al.. (2017). Dyrk1 inhibition improves Alzheimer's disease‐like pathology. Aging Cell. 16(5). 1146–1154. 87 indexed citations
12.
Medda, Federico, Hui Hua Chang, Justin Dietrich, et al.. (2012). Synthesis and biological activity of aminophthalazines and aminopyridazines as novel inhibitors of PGE2 production in cells. Bioorganic & Medicinal Chemistry Letters. 23(2). 528–531. 11 indexed citations
13.
Smith, Breland E., Hui Hua Chang, Federico Medda, et al.. (2012). Synthesis and biological activity of 2-aminothiazoles as novel inhibitors of PGE2 production in cells. Bioorganic & Medicinal Chemistry Letters. 22(10). 3567–3570. 44 indexed citations
14.
Smith, Breland E., Federico Medda, Vijay Gokhale, Travis Dunckley, & Christopher Hulme. (2012). Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?. ACS Chemical Neuroscience. 3(11). 857–872. 122 indexed citations
15.
Lash, Timothy D., et al.. (2011). Synthesis of Indenoporphyrins, Highly Modified Porphyrins with Reduced Diatropic Characteristics. The Journal of Organic Chemistry. 76(13). 5335–5345. 28 indexed citations
16.
Smith, Breland E. & Timothy D. Lash. (2010). Porphyrins with exocyclic rings. Part 25: synthesis of porphyrins with a fused cyclic ether subunit from tetrahydro-4H-pyan-4-one. Tetrahedron. 66(25). 4413–4422. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davide Guerrieri Breakdown of academic impact, for papers by Jakub Wojcieszak Breakdown of academic impact, for papers by Susan L. Mercer Breakdown of academic impact, for papers by Noriyuki Usami Breakdown of academic impact, for papers by Ling‐Wei Hsin Breakdown of academic impact, for papers by Azza Baraka Breakdown of academic impact, for papers by F. Shalit Breakdown of academic impact, for papers by Kamila Czarnecka Breakdown of academic impact, for papers by Ewelina Honkisz-Orzechowska Breakdown of academic impact, for papers by Paolo Lazzari
Rankless by CCL
2026